Keyword Analysis & Research: siolta therapeutics
Keyword Research: People who searched siolta therapeutics also searched
Search Results related to siolta therapeutics on Search Engine
-
Home - Siolta Therapeutics
https://www.sioltatherapeutics.com/
WEBJul 20, 2022 · The future of precision medicine starts here. Our mission is to develop targeted live biotherapeutics and molecular diagnostic tools that target the core drivers of diseases of high unmet medical need. See Our Pipeline.
DA: 57 PA: 36 MOZ Rank: 72
-
About - Siolta Therapeutics
https://www.sioltatherapeutics.com/about/
WEBDeveloping live biotherapeutics that target the core drivers of disease. We leverage our deep knowledge of the human microbiome and its regulatory and developmental functions to develop live biotherapeutic products (LBPs) and diagnostics for the prevention and treatment of a wide range of diseases.
DA: 21 PA: 4 MOZ Rank: 7
-
Pipeline - Siolta Therapeutics
https://www.sioltatherapeutics.com/pipeline/
WEBOur unique platform is designed to address multiple targets across a wide range of diseases. With clinical studies underway for allergic diseases, we are broadening our portfolio in the “maternal-infant axis” by advancing programs for recurrent bacterial vaginosis and necrotizing enterocolitis.
DA: 36 PA: 8 MOZ Rank: 59
-
Our Science - Siolta Therapeutics
https://www.sioltatherapeutics.com/our-science/
WEBSiolta’s science focuses on designing consortia of microbes that promote microbiome development in early life and adult women to prevent immune dysfunction and/or the onset or recurrence of infections.
DA: 30 PA: 85 MOZ Rank: 50
-
Our Platform - Siolta Therapeutics
https://www.sioltatherapeutics.com/our-platform/
WEBA platform focused on translating microbiome science into novel therapeutics for a healthier world. Siolta’s patient-centric platform leverages our internal expertise in microbiome data analysis, machine learning, anaerobic microbiology, and translational studies to rationally design and optimize multi-strain live biotherapeutics for the ...
DA: 43 PA: 38 MOZ Rank: 36
-
Siolta Therapeutics Raises $12 Million in Series C Financing for
https://finance.yahoo.com/news/siolta-therapeutics-raises-12-million-110000531.html
WEBBusiness Wire. Thu, Mar 14, 2024 3 min read. SAN CARLOS, Calif., March 14, 2024 -- ( BUSINESS WIRE )--Siolta Therapeutics, a clinical-stage biotech company, has announced the completion of a...
DA: 28 PA: 2 MOZ Rank: 67
-
News - Siolta Therapeutics
https://www.sioltatherapeutics.com/press/news/
WEBJul 20, 2022 · News. Siolta successfully doses first newborn in phase 2 study. Groundbreaking trial of STMC-103H for the prevention of atopic diseases. July 20, 2022. Read More. News. Siolta Therapeutics awarded NIH grant funding. Advance Technology Small Business Innovation Grant Award from NIAID. February 9, 2022.
DA: 92 PA: 32 MOZ Rank: 99
-
Siolta Therapeutics Announces First Newborn Dosed in Their …
https://www.businesswire.com/news/home/20220726005014/en/%C2%A0Siolta-Therapeutics-Announces-First-Newborn-Dosed-in-Their-Phase-2-ADORED-Study-Evaluating-a-Potential-First-In-Class-Live-Biotherapeutic-Product-for-the-Prevention-of-Atopic-Diseases
WEBJul 20, 2022 · Siolta Therapeutics is a clinical-stage biopharmaceutical company developing targeted microbiome-based therapeutics to prevent and treat diseases of high unmet medical need. Its lead program,...
DA: 18 PA: 14 MOZ Rank: 72
-
Siolta Therapeutics | LinkedIn
https://www.linkedin.com/company/siolta-therapeutics
WEBSiolta Therapeutics is a clinical-stage biotech company developing live biotherapeutics to improve outcomes in conditions with unmet medical needs. Our offices and laboratory are located in San...
DA: 15 PA: 42 MOZ Rank: 79
-
Human Microbiome - Siolta Therapeutics
https://www.sioltatherapeutics.com/our-science/human-microbiome/
WEBWe are only beginning to truly appreciate the power of this microbial organ on our health and wellness. Numerous aspects of modern life, including the widespread use of microbiome-altering medications, have wreaked havoc on the proper development, equilibrium, and diversity of the human microbiome.
DA: 41 PA: 72 MOZ Rank: 55
